Related Experiment Video
Updated: May 7, 2026

11:25
Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
6.7K
Optimizing Gene Sources for L-asparaginase Production: A Comparative Review
Vida Ebrahimi1, Atieh Hashemi2
1Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, No. 2660, Valiasr-Niayesh Junction, Vali-E-Asr Ave, Tehran, 19968-35113, Iran.
Current Microbiology
|July 11, 2025
Summary
This review assesses L-asparaginase gene sources for cancer therapy and food safety. Application-driven gene selection optimizes enzyme performance, leading to improved therapeutic and food production outcomes.
Area of Science:
- Biochemistry
- Biotechnology
- Enzyme Engineering
Background:
- L-asparaginase is crucial for treating acute lymphoblastic leukemia by depleting L-asparagine.
- The enzyme also reduces acrylamide formation in high-heat processed starchy foods, enhancing food safety.
- Enzyme performance, stability, immunogenicity, and production feasibility are significantly influenced by gene source.
Purpose of the Study:
- To systematically review and evaluate L-asparaginase gene sources.
- To assess the suitability of different gene sources for specific applications, including cancer therapy, food safety, and biosensing.
- To highlight the benefits of application-driven gene sourcing for developing improved L-asparaginase variants.
Main Methods:
- Comprehensive literature search across major biomedical databases.
- Systematic assessment of L-asparaginase gene sources based on application-specific criteria.
- Comparative analysis of enzyme properties derived from various gene origins.
Main Results:
- Identified key L-asparaginase gene sources and their characteristics.
- Demonstrated correlation between gene source and enzyme efficacy, stability, and immunogenicity.
- Highlighted specific gene sources optimal for therapeutic versus food industry applications.
Conclusions:
- Application-driven gene sourcing is essential for optimizing L-asparaginase.
- This approach can lead to safer, more effective, and economically viable enzyme variants.
- Provides insights for future advancements in enzyme design and deployment for clinical and industrial use.
More Related Videos
Related Concept Videos
Bioreactor Controls-III
70
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
70
Production of Pharmaceuticals
99
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
99

